PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
11-Aug-2021 DFE Pharma demonstrates Impact of Powder Properties on the Rheological Behavior of Excipients DFE Pharma
11-Aug-2021 ViewMind announces developer agreement with HP to help revolutionise the diagnosis and treatment of cognitive disorders ViewMind
11-Aug-2021 Mission and AbbVie Collaboration in Alzheimer’s and Parkinson’s Diseases Reaches Next Milestone Mission Therapeutics
11-Aug-2021 ASLAN PHARMACEUTICALS REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE ASLAN PHARMACEUTICALS
11-Aug-2021 NICE RECOMMENDS KITE’S TECARTUS®▼ FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA (MCL) AFTER TWO OR MORE LINES OF SYSTEMIC THERAPY INCLUDING A BRUTON’S TYROSINE KINASE (BTK) INHIBITOR IN ENGLAND WITHIN THE CANCER DRUGS FUND Kite
11-Aug-2021 Polyplus launches FectoVIR(R)-AAV GMP transfection reagent for large scale viral vector production to overcome commercial gene and cell therapy manufacturing barriers Polyplus
11-Aug-2021 Nouscom highlights innovative science behind VENUS, its novel algorithm for identifying and prioritizing patient-specific tumor neoantigens for personalized cancer immunotherapy Nouscom
11-Aug-2021 GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex GW Pharmaceuticals
11-Aug-2021 Santen and Sydnexis execute an exclusive licensing agreement for SYD-101, a novel investigational treatment for progressive childhood myopia Santen and Sydnexis
11-Aug-2021 Subscription to raise £1,000,000 to progress proprietary TYK2/JAK1 programmes into clinical development Sareum Holdings plc
11-Aug-2021 FORXIGA (dapagliflozin) APPROVED IN GREAT BRITAIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE AstraZeneca
11-Aug-2021 Forxiga approved in the EU for the treatment of chronic kidney disease in patients with and without type-2 diabetes AstraZeneca
11-Aug-2021 Just - Evotec Biologics opens J.POD® 1 US in Redmond, Washington Evotec
11-Aug-2021 HUTCHMED and Epizyme Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China HUTCHMED
11-Aug-2021 FDA approves Nexviazyme® (avalglucosidase alfa-ngpt), an important new treatment option for late-onset Pompe disease Sanofi
10-Aug-2021 F-star Therapeutics is Granted Composition of Matter Patent for its Novel Second Generation STING Agonist, SB 11285 F-star Therapeutics
10-Aug-2021 Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing to Canada Moderna
10-Aug-2021 VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody Drugs B3C newswire
09-Aug-2021 Eckert & Ziegler Receives Manufacturing Authorization for Thorium and Lutetium Compounds Eckert & Ziegler Strahlen- und Medizintechnik AG
06-Aug-2021 BD and CerTest Biotec Announce CE Mark for Molecular Test to Detect, Identify Certain SARS-CoV-2 Variants B3C newswire